V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280009515 | 280006784 | 1.8 | 56.7 | Palliative (P) | 2019-06-01 | 2019-06-11 | Cisplatin + Fluorouracil + RT 5day | null | null | 280026659 | DACTINOMYCIN + VINCRISTINE |
| 280009516 | 280006785 | 1.62 | 62.5 | Palliative (P) | null | 2019-01-07 | BUSULFAN + MELPHALAN | 2 | N | 280026665 | MITOMYCIN INTRAVESICULAR |
| 280009517 | 280006786 | 1.75 | 69 | Palliative (P) | 2017-08-08 | 2017-08-08 | Bevacizumab + Cape + Oxali 14day | N | N | 280027546 | BUSULFAN + MELPHALAN |
| 280009518 | 280006787 | 1.61 | null | Curative (C) | 2015-10-22 | 2015-10-30 | Docetaxel 75mg/m2 (21 day) | N | N | 280028140 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280009519 | 280006787 | 1.87 | null | Palliative (P) | 2018-01-08 | 2018-02-26 | IFOSFAMIDE + VINCRISTINE | 02 | N | 280028140 | CARBO + FLUOROURACIL |
| 280009520 | 280006788 | 1.52 | 92.9 | Adjuvant (A) | 2018-05-14 | 2018-05-19 | Cyclophosphamide PO +Vinorelbine IV | 02 | N | 280016754 | CISPLATIN + FLUOROURACIL + RT |
| 280009521 | 280006789 | 1.7 | null | Palliative (P) | 2019-08-10 | 2019-08-14 | CAPECITABINE + TEMOZOLOMIDE | N | N | 280016754 | PEMBROLIZUMAB |
| 280009522 | 280010840 | 1.84 | 78.7 | Palliative (P) | null | 2018-05-16 | FCR | null | null | 280026551 | CAPECITABINE + CISPLATIN |
| 280009523 | 280004141 | 1.75 | 72.4 | Palliative (P) | 2014-01-26 | 2014-03-17 | Trabectedin | 02 | Y | 280000089 | TRABECTEDIN |
| 280009524 | 280004146 | 1.77 | 90.3 | Palliative (P) | 2014-03-23 | 2014-03-23 | Trabectedin | 2 | N | 280000129 | TRABECTEDIN |
| 280009525 | 280004146 | 1.69 | 108.8 | Curative (C) | 2014-12-03 | 2015-03-03 | CISPLATIN + RT | N | Y | 280000129 | CISPLATIN + RT |
| 280009526 | 280004150 | 1.71 | 85 | Curative (C) | null | 2014-05-26 | Cisplatin + Radiotherapy | null | null | 280000567 | CISPLATIN + RT |
| 280009527 | 280004151 | 1.98 | 50.4 | null | 2013-06-11 | 2013-06-12 | Cisplatin + Radiotherapy | Y | N | 280000588 | CISPLATIN + RT |
| 280009529 | 280004155 | 1.8 | 90.5 | Neo-adjuvant (N) | 2014-05-21 | 2014-06-02 | Cisplatin + Radiotherapy | 02 | N | 280000867 | CISPLATIN + RT |
| 280009530 | 280004156 | 1.77 | 102.8 | Curative (C) | 2015-11-28 | 2015-12-14 | Cisplatin 100 + RT(H&N) 1 day | 2 | Y | 280000909 | CISPLATIN + RT |
| 280009531 | 280004157 | null | null | Curative (C) | 2014-05-04 | 2014-03-27 | Trial Unspecified | null | null | 280001073 | TRIAL |
| 280009532 | 280004161 | 1.75 | 53.8 | Palliative (P) | 2018-08-26 | 2018-08-31 | Trabectedin | 02 | N | 280001206 | TRABECTEDIN |
| 280009533 | 280004162 | 1.78 | 73 | Adjuvant (A) | 2013-12-27 | 2014-01-21 | Cisplatin + Radiotherapy | N | Y | 280001303 | CISPLATIN + RT |
| 280009534 | 280011621 | 1.71 | 51.8 | Curative (C) | 2018-08-04 | 2018-09-05 | CISPLATIN + RT | 2 | N | 280001313 | CISPLATIN + RT |
| 280009535 | 280004164 | 1.77 | null | Curative (C) | 2014-08-07 | 2014-08-23 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | 280001326 | CISPLATIN + RT |
| 280009536 | 280004166 | 1.57 | 74.2 | Neo-adjuvant (N) | 2015-05-03 | 2015-05-14 | Cisplatin + Radiotherapy | N | N | 280001564 | CISPLATIN + RT |
| 280009538 | 280004174 | 1.7 | 78 | Curative (C) | 2017-01-08 | 2017-01-14 | Cisplatin 100 + RT(H&N) 1 day | N | N | 280002257 | CISPLATIN + RT |
| 280009539 | 280010181 | 1.75 | 65 | Curative (C) | 2014-09-25 | 2014-10-05 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 280002286 | CISPLATIN + RT |
| 280009540 | 280004176 | 1.7 | 81 | Curative (C) | 2015-02-24 | 2015-02-24 | Cisplatin + Radiotherapy | 02 | N | 280002366 | CISPLATIN + RT |
| 280009541 | 280004181 | null | 108.35 | Curative (C) | 2013-08-20 | 2013-08-20 | CISPLATIN + RT | 2 | null | 280002818 | CISPLATIN + RT |
| 280009543 | 280004184 | 1.77 | 71.9 | Curative (C) | 2017-09-12 | 2017-09-24 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 280003023 | CISPLATIN + RT |
| 280009544 | 280004185 | 1.7 | 63 | Palliative (P) | 2013-10-31 | 2014-01-28 | Trabectedin | 2 | Y | 280003064 | TRABECTEDIN |
| 280009545 | 280008258 | 1.7 | 71.4 | Palliative (P) | 2018-01-09 | 2018-01-16 | Trabectedin | N | null | 280003134 | TRABECTEDIN |
| 280009552 | 280004193 | 1.75 | 103.6 | Disease modification (D) | 2015-07-18 | 2015-10-12 | Trial Unspecified | N | N | 280003779 | TRIAL |
| 280009553 | 280004198 | 1.72 | 54.8 | Neo-adjuvant (N) | 2013-05-15 | 2014-02-27 | Trial Unspecified | Y | N | 280004147 | TRIAL |
| 280009554 | 280008267 | 1.76 | 106 | Palliative (P) | 2013-09-18 | 2013-12-20 | Trabectedin | 01 | N | 280004289 | TRABECTEDIN |
| 280009555 | 280004201 | 1.58 | 59.4 | Curative (C) | null | 2017-08-17 | EW EuroEwing 2012 Arm B IE | 2 | Y | 280004547 | TRIAL |
| 280009556 | 280004204 | 1.65 | null | Curative (C) | 2015-09-07 | 2015-09-08 | CISPLATIN + RT | N | Y | 280004859 | CISPLATIN + RT |
| 280009558 | 280011989 | 1.78 | 81.8 | Palliative (P) | 2014-07-27 | 2014-08-20 | EW EuroEwing 2012 Arm B IE | null | null | 280005206 | TRIAL |
| 280009561 | 280004215 | 1.8 | 82.3 | Curative (C) | 2014-05-01 | 2014-05-07 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 280005702 | CISPLATIN + RT |
| 280009562 | 280004217 | 0 | 111 | Adjuvant (A) | null | 2017-08-09 | Cisplatin + Radiotherapy | N | N | 280005726 | CISPLATIN + RT |
| 280009564 | 280004225 | null | null | Curative (C) | 2013-07-22 | 2013-08-27 | Cisplatin 100 + RT(H&N) 1 day | Y | N | 280006027 | CISPLATIN + RT |
| 280009565 | 280004228 | 1.73 | 72.7 | Curative (C) | 2014-10-30 | 2014-10-30 | Cisplatin 100 + RT(H&N) 1 day | Y | Y | 280006208 | CISPLATIN + RT |
| 280009566 | 280004229 | null | 80.9 | Palliative (P) | 2015-02-14 | 2015-02-14 | EW EuroEwing 2012 Arm B IE | N | null | 280006334 | TRIAL |
| 280009568 | 280004234 | 1.69 | 97.3 | Curative (C) | 2014-09-01 | 2014-10-04 | CISPLATIN + RT | N | Y | 280006539 | CISPLATIN + RT |
| 280009569 | 280010201 | 1.77 | 46 | Palliative (P) | 2016-11-07 | 2016-11-28 | Trabectedin | 02 | Y | 280006597 | TRABECTEDIN |
| 280009570 | 280004241 | 1.69 | 46 | null | null | 2013-07-27 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 280006629 | CISPLATIN + RT |
| 280009571 | 280004243 | null | 76.5 | Curative (C) | 2013-01-21 | 2013-02-12 | Cisplatin + Radiotherapy | Y | null | 280006666 | CISPLATIN + RT |
| 280009572 | 280004244 | 1.65 | 55.2 | Neo-adjuvant (N) | 2015-04-19 | 2015-05-14 | Trial Unspecified | 02 | N | 280006758 | TRIAL |
| 280009573 | 280004246 | 1.69 | 53.3 | null | 2017-04-06 | 2017-04-06 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 280006861 | CISPLATIN + RT |
| 280009574 | 280004247 | 1.73 | 46.9 | Palliative (P) | 2016-07-22 | 2016-07-24 | Trial Unspecified | Y | Y | 280006981 | TRIAL |
| 280009575 | 280004248 | 1.79 | 134.4 | Curative (C) | 2016-09-08 | 2016-10-04 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 280006989 | CISPLATIN + RT |
| 280009576 | 280004249 | 1.8 | 118.3 | Palliative (P) | 2015-08-22 | 2015-12-04 | Trial Unspecified | 02 | N | 280006990 | TRIAL |
| 280009577 | 280004252 | 1.66 | 58.4 | Curative (C) | 2014-11-21 | 2014-11-21 | CISPLATIN + RT | 02 | Y | 280007207 | CISPLATIN + RT |
| 280009578 | 280004257 | 1.62 | 89.3 | Adjuvant (A) | 2018-06-12 | 2018-06-19 | EW EuroEwing 2012 Arm B VDC | 2 | Y | 280007377 | TRIAL |